State-wise Number of Vials of Remdesivir, Tocilizumab and Amphotericin B Supplied for Treatment of COVID-19 Infections by Pharmaceutical Companies Against Allocation Given by Central Government in Northern States of India (As on 25.07.2021) | |||
States/UTs | Remdesivir | Tocilizumab | Amphotericin B |
Chandigarh | |||
Delhi | |||
Haryana | |||
Himachal Pradesh | |||
Jammu & Kashmir | |||
Ladakh | |||
Punjab | |||
Rajasthan | |||
Uttar Pradesh | |||
Uttarakhand | |||
Northern States | |||
India |